当前位置:首页 - 行情中心 - 丹科B股(900921) - 财务分析 - 利润表

丹科B股

(900921)

  

流通市值:2325.52万  总市值:1.22亿
流通股本:1.94亿   总股本:10.17亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入649,641,860.35498,911,846.49233,516,090.43933,819,345.78
营业收入649,641,860.35498,911,846.49233,516,090.43933,819,345.78
二、营业总成本883,182,200.68613,121,433.23287,587,246.591,092,431,496.67
营业成本745,711,098.91518,237,833.26243,945,603.47889,389,412.2
税金及附加16,032,947.3312,904,963.265,367,735.121,050,993.36
销售费用2,084,816.131,606,007.62907,708.922,189,525.27
管理费用84,535,764.9256,221,537.6925,625,874.63119,659,286.28
研发费用25,322,704.0617,961,345.319,247,881.1847,316,191.43
财务费用9,494,869.336,189,746.092,492,443.2912,826,088.13
其中:利息费用9,521,705.596,223,566.92,530,105.2713,058,009.71
其中:利息收入128,623.7104,937.572,977.42300,764.22
加:投资收益-2,902,791.15-2,201,982.19315,135.26-8,390,697.69
资产处置收益99,694-111,120.82-25,238.33582,159.94
资产减值损失(新)----58,495,929.05
信用减值损失(新)2,666,819.642,523,059.82--4,813,981.59
其他收益3,680,906.862,636,368.771,455,618.884,542,449.58
营业利润平衡项目0000
四、营业利润-229,995,710.98-111,363,261.16-52,325,640.35-225,188,149.7
加:营业外收入3,920,465.39104,706.8932,504.892,032,547.4
减:营业外支出109,397.2183,207.5881,0901,351,565.11
利润总额平衡项目0000
五、利润总额-226,184,642.8-111,341,761.85-52,374,225.46-224,507,167.41
减:所得税费用1,030,411.511,128,616.88532,008.87153,462,891.28
六、净利润-227,215,054.31-112,470,378.73-52,906,234.33-377,970,058.69
持续经营净利润-227,215,054.31-112,470,378.73-52,906,234.33-377,970,058.69
归属于母公司股东的净利润-175,903,914.13-87,145,133.83-40,813,164.81-292,983,780.21
少数股东损益-51,311,140.18-25,325,244.9-12,093,069.52-84,986,278.48
(一)基本每股收益-0.17-0.09-0.04-0.29
(二)稀释每股收益-0.17-0.09-0.04-0.29
八、其他综合收益-593,643.96-849,725.0998,830.64-8,158,545.49
归属于母公司股东的其他综合收益-593,643.96-849,725.0998,830.64-6,153,253.91
九、综合收益总额-227,808,698.27-113,320,103.82-52,807,403.69-386,128,604.18
归属于母公司股东的综合收益总额-176,497,558.09-87,994,858.92-40,714,334.17-299,137,034.12
归属于少数股东的综合收益总额-51,311,140.18-25,325,244.9-12,093,069.52-86,991,570.06
公告日期2023-10-282023-08-312023-04-292023-04-21
审计意见(境内)带强调事项段的无保留意见
TOP↑